Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6BVW

SFTI-HFRW-3

Summary for 6BVW
Entry DOI10.2210/pdb6bvw/pdb
NMR InformationBMRB: 30381
DescriptorTrypsin inhibitor 1 HFRW-3 (1 entity in total)
Functional Keywordsmelanocortin, pharmacophore, cyclic peptide, biosynthetic protein
Biological sourceHelianthus annuus (common sunflower)
Total number of polymer chains1
Total formula weight1717.07
Authors
Schroeder, C.I. (deposition date: 2017-12-14, release date: 2018-12-19, Last modification date: 2023-11-15)
Primary citationDurek, T.,Cromm, P.M.,White, A.M.,Schroeder, C.I.,Kaas, Q.,Weidmann, J.,Ahmad Fuaad, A.,Cheneval, O.,Harvey, P.J.,Daly, N.L.,Zhou, Y.,Dellsen, A.,Osterlund, T.,Larsson, N.,Knerr, L.,Bauer, U.,Kessler, H.,Cai, M.,Hruby, V.J.,Plowright, A.T.,Craik, D.J.
Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.
J.Med.Chem., 61:3674-3684, 2018
Cited by
PubMed Abstract: Ultrastable cyclic peptide frameworks offer great potential for drug design due to their improved bioavailability compared to their linear analogues. Using the sunflower trypsin inhibitor-1 (SFTI-1) peptide scaffold in combination with systematic N-methylation of the grafted pharmacophore led to the identification of novel subtype selective melanocortin receptor (MCR) agonists. Multiple bicyclic peptides were synthesized and tested toward their activity at MC1R and MC3-5R. Double N-methylated compound 18 showed a p K of 8.73 ± 0.08 ( K = 1.92 ± 0.34 nM) and a pEC of 9.13 ± 0.04 (EC = 0.75 ± 0.08 nM) at the human MC1R and was over 100 times more selective for MC1R. Nuclear magnetic resonance structural analysis of 18 emphasized the role of peptide bond N-methylation in shaping the conformation of the grafted pharmacophore. More broadly, this study highlights the potential of cyclic peptide scaffolds for epitope grafting in combination with N-methylation to introduce receptor subtype selectivity in the context of peptide-based drug discovery.
PubMed: 29605997
DOI: 10.1021/acs.jmedchem.8b00170
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon